Guoyin Li

824 total citations
35 papers, 584 citations indexed

About

Guoyin Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guoyin Li has authored 35 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Guoyin Li's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Immunotherapy and Immune Responses (5 papers). Guoyin Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Immunotherapy and Immune Responses (5 papers). Guoyin Li collaborates with scholars based in China and United States. Guoyin Li's co-authors include Zewen Song, Wei Zheng, Xuan Dong, Mark C. Kelley, Xiao‐Ou Shu, Jirong Long, Angang Yang, Lei Wang, Sandra Deming-Halverson and Qiuyin Cai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Guoyin Li

30 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guoyin Li China	13	343	230	156	111	57	35	584
Songping Xie China	15	349 1.0×	220 1.0×	134 0.9×	90 0.8×	50 0.9×	40	579
Yun Xu China	17	360 1.0×	265 1.2×	179 1.1×	101 0.9×	101 1.8×	52	732
Zehua Wang China	13	275 0.8×	187 0.8×	185 1.2×	103 0.9×	60 1.1×	32	562
Xiaolin Lin China	15	388 1.1×	240 1.0×	142 0.9×	64 0.6×	39 0.7×	31	579
Satoe Fujiwara Japan	14	279 0.8×	169 0.7×	227 1.5×	72 0.6×	89 1.6×	38	677
Shengli Dong China	14	361 1.1×	227 1.0×	130 0.8×	47 0.4×	59 1.0×	40	580
Yifei Feng China	14	508 1.5×	250 1.1×	161 1.0×	80 0.7×	36 0.6×	28	664
Ori Hassin Israel	6	307 0.9×	136 0.6×	264 1.7×	75 0.7×	39 0.7×	8	522
Ertao Zhai China	14	350 1.0×	139 0.6×	195 1.3×	147 1.3×	95 1.7×	30	605
Xinguo Zhu China	15	410 1.2×	301 1.3×	222 1.4×	70 0.6×	64 1.1×	35	713

Countries citing papers authored by Guoyin Li

Since Specialization

Citations

This map shows the geographic impact of Guoyin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyin Li more than expected).

Fields of papers citing papers by Guoyin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyin Li. The network helps show where Guoyin Li may publish in the future.

Co-authorship network of co-authors of Guoyin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guoyin Li. A scholar is included among the top collaborators of Guoyin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoyin Li. Guoyin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Lili, Weidong Shi, Weifeng Peng, & Guoyin Li. (2025). Unraveling the interplay between meningitis and mitochondria: Etiology, pathogenesis, and therapeutic insights. International Immunopharmacology. 147. 113985–113985. 1 indexed citations

Guo, Xiaoyu, Jiajun Hu, Tong Lu, Guoyin Li, & Ruoxiu Xiao. (2025). A novel vessel enhancement method based on Hessian matrix eigenvalues using multilayer perceptron. Bio-Medical Materials and Engineering. 36(2). 83–97.

Li, Guoyin, Yi Zhao, Zhengzi Qian, et al.. (2025). Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma. Scientific Reports. 15(1). 30417–30417.

Deng, Fu‐An, Yijun Wang, Guoyin Li, et al.. (2024). In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy. Nature Communications. 15(1). 9723–9723. 8 indexed citations

Tian, Xu, Hui Xiang, Jing Liang, et al.. (2024). Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy. BMC Cancer. 24(1). 1198–1198.

Li, Xiaoyan, Jing Kang, Huina Zhang, et al.. (2023). Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy. Aging. 15(9). 3442–3464. 6 indexed citations

Li, Xiaoyan, Jinping Wang, Yong Ma, et al.. (2023). Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. Aging. 15(24). 15084–15113. 10 indexed citations

Liu, Qiuping, Guoyin Li, Xiaomeng Liu, et al.. (2023). Cancer stem cells and their niche in cancer progression and therapy. Cancer Cell International. 23(1). 305–305. 35 indexed citations

Wu, Huihuan, et al.. (2023). Case Report: Toripalimab: a novel immune checkpoint inhibitor in advanced nasopharyngeal carcinoma and severe immune-related colitis. Frontiers in Immunology. 14. 1298902–1298902. 4 indexed citations

10.

Li, Guoyin, et al.. (2023). Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma. Aging. 15(7). 2667–2688. 4 indexed citations

11.

Li, Guoyin, Zewen Song, Yi Ru, et al.. (2023). Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment. SHILAP Revista de lepidopterología. 3(5). 20220141–20220141. 31 indexed citations

12.

Zhu, Zheng, Guoyin Li, Zhenning Li, et al.. (2022). Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma. Frontiers in Immunology. 13. 914612–914612. 8 indexed citations

13.

Li, Guoyin, Zewen Song, Changjing Wu, et al.. (2022). Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma. Journal of Translational Medicine. 20(1). 47–47. 13 indexed citations

14.

Cui, Xiang, Shanshan Deng, Guoyin Li, et al.. (2022). Butenolide derivatives from Aspergillus terreus selectively inhibit butyrylcholinesterase. Frontiers in Chemistry. 10. 1063284–1063284. 3 indexed citations

15.

Zhao, Hui, Junjun Zhang, Xiaoliang Fu, et al.. (2021). Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer. PeerJ. 9. e11880–e11880. 9 indexed citations

16.

Deng, Yali, Zewen Song, Li Huang, et al.. (2021). Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer. Aging. 13(22). 24768–24785. 39 indexed citations

17.

Wu, Ying, Bohua Yan, W. Xu, et al.. (2020). Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway. International Journal of Biological Sciences. 16(4). 583–597. 22 indexed citations

18.

Lu, Xiaofang, et al.. (2019). Next-generation sequencing yields the complete chloroplast genome of Abies fanjingshanensis, an Endangered species from South China. SHILAP Revista de lepidopterología. 4(1). 880–881. 4 indexed citations

19.

Li, Guoyin, et al.. (2016). DPYD*2A/*5A/*9A and UGT1A1*6/*28 polymorphisms in Chinese colorectal cancer patients. Journal of Cancer Research and Therapeutics. 12(2). 782–786. 6 indexed citations

20.

He, Shiming, et al.. (2012). Down-regulation of Nedd4L is Associated with the Aggressive Progression and Worse Prognosis of Malignant Glioma. Japanese Journal of Clinical Oncology. 42(3). 196–201. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact